U.S. Markets open in 4 hrs 40 mins

Progenics Pharmaceuticals, Inc. (PGNX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.61+0.04 (+0.61%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close6.57
Bid5.19 x 100
Ask8.94 x 1000
Day's Range6.57 - 6.67
52 Week Range4.84 - 11.72
Avg. Volume853,612
Market Cap464.19M
PE Ratio (TTM)68.14
EPS (TTM)0.1
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.50
Trade prices are not sourced from all markets
  • GlobeNewswire12 hours ago

    Progenics Pharmaceuticals Sets Second Quarter 2017 Financial Results Call for August 9

    NEW YORK, July 26, 2017-- Progenics Pharmaceuticals, Inc.,, an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that it will host a ...

  • Capital Cube2 days ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : July 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Benzinga15 days ago

    Progenics Shares Could Double, According To Cantor

    Cantor Fitzgerald analyst Mara Goldstein initiated coverage on Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ) with an Overweight rating and $15 price target. The stock jumped 2.4 percent Wednesday to ...